Rajendram R - Search Results

1

Effect of glycosylated hemoglobin on response to ranibizumab therapy in diabetic macular edema: real-world outcomes in 312 patients.

Shalchi Z, Okada M, Bruynseels A, Palethorpe D, Yusuf A, Hussain R, Herrspiegel C, Scazzarriello A, Habib A, Amin R, Rajendram R. Shalchi Z, et al. Among authors: rajendram r. Can J Ophthalmol. 2018 Aug;53(4):415-419. doi: 10.1016/j.jcjo.2017.10.008. Epub 2017 Dec 16. Can J Ophthalmol. 2018. PMID: 30119798

2

A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2.

Michaelides M, Kaines A, Hamilton RD, Fraser-Bell S, Rajendram R, Quhill F, Boos CJ, Xing W, Egan C, Peto T, Bunce C, Leslie RD, Hykin PG. Michaelides M, et al. Among authors: rajendram r. Ophthalmology. 2010 Jun;117(6):1078-1086.e2. doi: 10.1016/j.ophtha.2010.03.045. Epub 2010 Apr 22. Ophthalmology. 2010. PMID: 20416952 Clinical Trial.

3

A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3.

Rajendram R, Fraser-Bell S, Kaines A, Michaelides M, Hamilton RD, Esposti SD, Peto T, Egan C, Bunce C, Leslie RD, Hykin PG. Rajendram R, et al. Arch Ophthalmol. 2012 Aug;130(8):972-9. doi: 10.1001/archophthalmol.2012.393. Arch Ophthalmol. 2012. PMID: 22491395 Clinical Trial.

4

Structural and functional measures of efficacy in response to bevacizumab monotherapy in diabetic macular oedema: exploratory analyses of the BOLT study (report 4).

Sivaprasad S, Crosby-Nwaobi R, Esposti SD, Peto T, Rajendram R, Michaelides M, Hykin P. Sivaprasad S, et al. Among authors: rajendram r. PLoS One. 2013 Aug 27;8(8):e72755. doi: 10.1371/journal.pone.0072755. eCollection 2013. PLoS One. 2013. PMID: 24013651 Free PMC article. Clinical Trial.

5

Patterns of peripheral retinal and central macula ischemia in diabetic retinopathy as evaluated by ultra-widefield fluorescein angiography.

Sim DA, Keane PA, Rajendram R, Karampelas M, Selvam S, Powner MB, Fruttiger M, Tufail A, Egan CA. Sim DA, et al. Among authors: rajendram r. Am J Ophthalmol. 2014 Jul;158(1):144-153.e1. doi: 10.1016/j.ajo.2014.03.009. Epub 2014 Apr 4. Am J Ophthalmol. 2014. PMID: 24709807

6

Real-World Outcomes of Ranibizumab Treatment for Diabetic Macular Edema in a United Kingdom National Health Service Setting.

Patrao NV, Antao S, Egan C, Omar A, Hamilton R, Hykin PG, Sivaprasad S, Rajendram R; Moorfields Diabetic Macular Edema Study Group. Patrao NV, et al. Among authors: rajendram r. Am J Ophthalmol. 2016 Dec;172:51-57. doi: 10.1016/j.ajo.2016.09.002. Epub 2016 Sep 13. Am J Ophthalmol. 2016. PMID: 27637784

7

Influence of baseline diabetic retinopathy status on initial anatomical response of intravitreal ranibizumab therapy for diabetic macular oedema.

Nicholson L, Patrao NV, Ramu J, Vazquez-Alfageme C, Muwas M, Rajendram R, Hykin PG, Sivaprasad S. Nicholson L, et al. Among authors: rajendram r. Eye (Lond). 2017 Sep;31(9):1358-1364. doi: 10.1038/eye.2017.69. Epub 2017 Apr 28. Eye (Lond). 2017. PMID: 28452992 Free PMC article.

8

Identification of time point to best define 'sub-optimal response' following intravitreal ranibizumab therapy for diabetic macular edema based on real-life data.

Chatziralli I, Santarelli M, Patrao N, Nicholson L, Zola M, Rajendram R, Hykin P, Sivaprasad S. Chatziralli I, et al. Among authors: rajendram r. Eye (Lond). 2017 Nov;31(11):1594-1599. doi: 10.1038/eye.2017.111. Epub 2017 Jun 16. Eye (Lond). 2017. PMID: 28622321 Free PMC article.

9

Three-Year Outcomes of Aflibercept Treatment for Neovascular Age-Related Macular Degeneration: Evidence from a Clinical Setting.

Eleftheriadou M, Gemenetzi M, Lukic M, Sivaprasad S, Hykin PG, Hamilton RD, Rajendram R, Tufail A, Patel PJ. Eleftheriadou M, et al. Among authors: rajendram r. Ophthalmol Ther. 2018 Dec;7(2):361-368. doi: 10.1007/s40123-018-0139-5. Epub 2018 Jul 7. Ophthalmol Ther. 2018. PMID: 29982914 Free PMC article.

10

Intravitreal aflibercept for diabetic macular oedema: Moorfields' real-world 12-month visual acuity and anatomical outcomes.

Lukic M, Williams G, Shalchi Z, Sim D, Patel PJ, Keane PA, Hykin PG, Sivaprasad S, Menon D, Bruynseels A, Hamilton RD, Rajendram R. Lukic M, et al. Among authors: rajendram r. Eur J Ophthalmol. 2020 May;30(3):557-562. doi: 10.1177/1120672119833270. Epub 2019 Feb 26. Eur J Ophthalmol. 2020. PMID: 30808179

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters